Active Substance & Generic Molecule Directory
Rhizoma Pinelliae Preparata in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Rhizoma Pinelliae Preparata registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
10
Registered Brands
Availability in Malaysia:10 Traditional (MAL-T)
Showing 10 of 10 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL06071283T | BTY CHUAN BEI PI PA HE JI (LIQUID) | 2.0 g 30 ml | Traditional Herbal (MAL-T) | BTY WORLDWIDE SDN.BHD. | Compare → |
| MAL11030049T | BTY CHUAN BEI PI PA KE LI (Granule) | 1.052 g 5 g | Traditional Herbal (MAL-T) | BTY WORLDWIDE SDN.BHD. | Compare → |
| MAL06111455T | BTY CHUAN XIONG HE JI (Liquid) | 2.73 g 30 ml | Traditional Herbal (MAL-T) | BTY WORLDWIDE SDN.BHD. | Compare → |
| MAL06100724T | BTY LIU JUN ZI HE JI (Liquid) | 3.1 g 30 ml | Traditional Herbal (MAL-T) | BTY WORLDWIDE SDN.BHD. | Compare → |
| MAL11030041T | BTY LIU JUN ZI KE LI (Granule) | 0.83 g 5 g | Traditional Herbal (MAL-T) | BTY WORLDWIDE SDN.BHD. | Compare → |
| MAL06091548T | BTY LIU JUN ZI PIAN (Tablet) | 66.42 mg 0.35 g | Traditional Herbal (MAL-T) | BTY WORLDWIDE SDN.BHD. | Compare → |
| MAL06071323T | BTY SHUN QI HUA TAN ZHI KE PIAN (Tablet) | 15.5 mg 0.35 g | Traditional Herbal (MAL-T) | BTY WORLDWIDE SDN.BHD. | Compare → |
| MAL06111489T | BTY TONG XUAN LI FEI PIAN PLUS (Tablet) | 21.80 mg 0.35 g | Traditional Herbal (MAL-T) | BTY WORLDWIDE SDN.BHD. | Compare → |
| MAL08042438T | BTY WEI SHU NING HE JI (Liquid) | 1.45 g 30 ml | Traditional Herbal (MAL-T) | BTY WORLDWIDE SDN.BHD. | Compare → |
| MAL19963129T | Tai Wah Erchen Tablet | 105MG | Traditional Herbal (MAL-T) | SG GLOBAL BIOTECH SDN. BHD. | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.